Civica Rx - "the nonprofit model for manufacturing." This piece, from The Medicine Maker magazine, shares highlights of our progress, our partners and our new sterile injectable manufacturing facility in City of Petersburg, VA.
Excerpts:
"All companies claim to put patients first, but how true is that really when the corporate pharma business revolves around profits? Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working...
"Civica is supplying nearly 80 different generic medicines to member hospitals – and has provided over 185 million doses to date. It has also opened its own manufacturing facility in Petersburg, Virginia, with the capacity to produce 90 million vials and 50 million pre-filled syringes of medicines every year...
"According to Civica's Jason Winfield, site director of engineering and technical services, there has been a big focus for some time on bringing production closer to home. 'A lot of pharmaceutical manufacturing takes place in India and China, but there have been widely publicized issues with sterile injectables. And although India is a great provider of APIs, they get a lot of their precursors from China. During the COVID-19 pandemic, materials stopped moving – and this hasn’t ended with COVID; there are still ongoing challenges in supply chains.'”
Excerpts from equipment partners:
From Matt Clifton, business development manager at groninger USA: "From the very start of Civica, the company was unique. A lot of people in the industry were watching them closely. They had smart people on the business side and significant industry leadership with a ton of manufacturing experience. However, I think there was some doubt early on about whether they could pull it off and if there would be any compromises on quality. But they’ve done it – their products are excellent and their facility is one of the best facilities I’ve visited. They use high-end solutions and they understand what they are doing. They are top tier in the industry.”
From SKAN's Marc Suter: “It’s hard not to feel personally moved when you hear the story behind Civica. Somebody needs to tackle drug shortages, but it may not be profitable to do so for some companies. The result is that patients have to go without their medicines. I’m proud to be part of a project that is trying to change that. Civica isn’t just focused on generic drugs; they also have plans to make affordable insulin. I really wasn’t aware of how difficult the situation is in the US compared with Europe, where I am based. If you follow through and stand with something, you can make changes in this industry. It’s been amazing to watch what Civica has done.”
Thanks to the teams at groninger & co. gmbh and SKAN for helping to bring our new manufacturing facility to life!
https://lnkd.in/eCB2ebgQ